Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke

BACKGROUND AND PURPOSE: Experimental stroke induces a biphasic effect on the immune response that involves early activation of peripheral leukocytes followed by severe immunodepression and atrophy of spleen and thymus. In tandem, the developing infarct is exacerbated by influx of numerous inflammato...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Subramanian, Sandhya, Zhang, Bing, Kosaka, Yasuharu, Burrows, Gregory G., Grafe, Marjorie R., Vandenbark, Arthur A., Hurn, Patricia D., Offner, Halina
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704258/
https://ncbi.nlm.nih.gov/pubmed/19443805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.108.543991
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia